These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11750405)

  • 21. Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation.
    Stravitz RT; Shiffman ML; Sanyal AJ; Luketic VA; Sterling RK; Heuman DM; Ashworth A; Mills AS; Contos M; Cotterell AH; Maluf D; Posner MP; Fisher RA
    Liver Transpl; 2004 Jul; 10(7):850-8. PubMed ID: 15237368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of Bcl-2/Bax mRNA in grafted liver during acute rejection after rat liver transplantation.
    Yamamoto H; Ohdan H; Shintaku S; Miyata Y; Marubayashi S; Asahara T; Ito H; Dohi K
    Transplant Proc; 1998 Nov; 30(7):2950-1. PubMed ID: 9838300
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of ischemic preconditioning on the genomic response to reperfusion injury in deceased donor liver transplantation.
    Jassem W; Fuggle S; Thompson R; Arno M; Taylor J; Byrne J; Heaton N; Rela M
    Liver Transpl; 2009 Dec; 15(12):1750-65. PubMed ID: 19938126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transplantation aspiration cytology in the diagnosis of steroid resistant rejection in liver allograft patients.
    Nashan B; Schlitt HJ; Ringe B; Bunzendahl H; Wonigeit K; Pichlmayr R
    Transplant Proc; 1990 Oct; 22(5):2297-8. PubMed ID: 2219376
    [No Abstract]   [Full Text] [Related]  

  • 25. Interleukin-12: a possible cytotoxic T-lymphocyte differentiation factor in allograft recipients.
    Gish RG; Krams SM; Martinez OM
    Transplant Proc; 1995 Feb; 27(1):459-60. PubMed ID: 7879061
    [No Abstract]   [Full Text] [Related]  

  • 26. c-Kit-positive mast cells in portal tracts cannot be used to distinguish acute cellular rejection from recurrent hepatitis C infection in liver allografts.
    Doria C; di Francesco F; Marino IR; Ramirez CB; Frank A; Iaria M; Galati SA; Farber JL
    Transplant Proc; 2006 Dec; 38(10):3597-600. PubMed ID: 17175342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic liver transplant rejection: definition and diagnosis.
    Wight DA
    Transplant Proc; 1996 Feb; 28(1):465-7. PubMed ID: 8644314
    [No Abstract]   [Full Text] [Related]  

  • 28. Banff schema for grading liver allograft rejection: utility in clinical practice.
    Ormonde DG; de Boer WB; Kierath A; Bell R; Shilkin KB; House AK; Jeffrey GP; Reed WD
    Liver Transpl Surg; 1999 Jul; 5(4):261-8. PubMed ID: 10388498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different cellular patterns associated with hepatitis C virus reactivation, cytomegalovirus infection, and acute rejection in liver transplant patients monitored with transplant aspiration cytology.
    Lautenschlager I; Nashan B; Schlitt HJ; Hoshino K; Ringe B; Tillmann HL; Manns M; Wonigeit K; Pichlmayr R
    Transplantation; 1994 Dec; 58(12):1339-45. PubMed ID: 7809926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination effect of tacrolimus and FTY720 in liver transplantation in rats.
    Tamura A; Li XK; Funeshima N; Enosawa S; Amemiya H; Suzuki S
    Transplant Proc; 1999 Nov; 31(7):2785-6. PubMed ID: 10578290
    [No Abstract]   [Full Text] [Related]  

  • 31. Correlation of FNAB with histology in human liver allografts. Regional experience.
    Lodererová A; Honsová E; Trunecka P; Wohl P; Vítko S
    Ann Transplant; 2001; 6(2):37-40. PubMed ID: 11803617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apoptosis and the expression of Fas and Fas-ligand antigen after orthotopic liver transplantation.
    Tannapfel A; Kohlhaw K; Schwarz R; Wenzke M; Köckerling F; Ebelt J; Hauss J; Wittekind C
    Transplant Proc; 1998 Aug; 30(5):2358-9. PubMed ID: 9723503
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevention of orthotopic liver allograft rejection in rats with a short-term brequinar sodium therapy. Analysis of intragraft cytokine gene expression.
    Shirwan H; Cosenza CA; Wang HK; Wu GD; Makowka L; Cramer DV
    Transplantation; 1994 Apr; 57(7):1072-80. PubMed ID: 8165706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The macrophage-derived T-cell growth factor interleukin-15 is present in interleukin-2-independent rejection after clinical heart and liver transplantation.
    Baan CC; Knoop CJ; Holweg CT; van Gelder T; Metselaar HJ; Niesters HG; Zondervan PE; Balk AH; Weimar W
    Transplant Proc; 1999 Nov; 31(7):2726-8. PubMed ID: 10578266
    [No Abstract]   [Full Text] [Related]  

  • 35. FK 506 used as rescue therapy for refractory liver allograft rejection.
    Chen CL; Eng HL; Chen YS; Kuo YC; Sun CK
    Transplant Proc; 1994 Aug; 26(4):1927-9. PubMed ID: 7520612
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of 1,25-dihydroxyvitamin D3 on preventing allograft from acute rejection following rat orthotopic liver transplantation.
    Zhang AB; Zheng SS; Jia CK; Wang Y
    World J Gastroenterol; 2003 May; 9(5):1067-71. PubMed ID: 12717858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Daily serum inflammatory cytokine (tumor necrosis factor-alpha, interleukin-6) monitoring in liver transplantation focusing on allograft rejection: a five-case report.
    Kita Y; Iwaki Y; Noguchi K; Tzakis AG; Todo S; Fung JJ; Starzl TE
    Transplant Proc; 1996 Jun; 28(3):1237-40. PubMed ID: 8658640
    [No Abstract]   [Full Text] [Related]  

  • 38. High expression of TIAF-1 in chronic kidney and liver allograft rejection and in activated T-helper cells.
    van der Leij J; van den Berg A; Albrecht EW; Blokzijl T; Roozendaal R; Gouw AS; de Jong KP; Stegeman CA; van Goor H; Chang NS; Poppema S
    Transplantation; 2003 Jun; 75(12):2076-82. PubMed ID: 12829915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic analysis of renal allograft dysfunction using cDNA microarrays.
    Sarwal M; Chang S; Barry C; Chen X; Alizadeh A; Salvatierra O; Brown P
    Transplant Proc; 2001; 33(1-2):297-8. PubMed ID: 11266826
    [No Abstract]   [Full Text] [Related]  

  • 40. Rapid therapeutic decision-making using frozen sections of human liver allograft biopsies.
    Louvel A; Icard P; Vigouroux C; Baudin F; Houssin D; Chapuis Y
    Transplant Proc; 1990 Oct; 22(5):2299. PubMed ID: 2219377
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.